Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.

The Journal of antimicrobial chemotherapy - 1 Nov 1999

Pong A, Thomson K S, Moland E S, Chartrand S A, Sanders C C

Abstract excerpt

A panel of 279 clinical isolates of Gram-positive cocci and Gram-negative bacilli with varying levels of resistance to ciprofloxacin were analysed for susceptibility to moxifloxacin, ciprofloxacin, ofloxacin and nalidixic acid. Moxifloxacin was eight- to 32-fold more potent than ciprofloxacin and ofloxacin against staphylococci and Streptococcus pneumoniae, and equivalent to eight-fold more potent against...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aza Compounds
Share to Ciprofloxacin
Share to Fluoroquinolones

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gram-Negative Bacteria

Share to Gram-Negative Bacterial Infections

Share to Gram-Positive Bacterial Infections

Share to Moxifloxacin

Share to Quinolines

Source

Identifiers

PMID: 10552978
DOI: 10.1093/jac/44.5.621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.PMID 10552978Read ↗

Activity of and resistance to moxifloxacin in Staphylococcus aureus.Semantic proximity Read ↗

The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.Semantic proximity Read ↗

Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumanniiSemantic proximity Read ↗

Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.Semantic proximity Read ↗

In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.Semantic proximity Read ↗

Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.Semantic proximity Read ↗

Comparative in-vitro activity of new quinolones against clinical isolates and resistant mutants.Semantic proximity Read ↗

In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus.Semantic proximity Read ↗

In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in TaiwanSemantic proximity Read ↗

Antibacterial activities of nemonoxacin against clinical isolates of Staphylococcus aureus: an in vitro comparison with three fluoroquinolones.Semantic proximity Read ↗

Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.Semantic proximity Read ↗

The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.